10x Genomics TXG
NASDAQ TXG
$63.20 +1.55 (+2.52%)
As of: Sep 3, 2026 · 3:59 PM EDT

10x Genomics (TXG) Free Cash Flow Growth (1y) (2019 - 2026)

Analysis

10x Genomics (TXG) Free Cash Flow Growth (1y) (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Veeva Systems 46.14 Bn 38.90 Bn 695.95 Mn -0.62%
2 BrightSpring Health Services 12.64 Bn 12.07 Bn 492.75 Mn -39.62%
3 Tempus AI 11.63 Bn 10.82 Bn 274.25 Mn -132.83%
4 Healthequity 8.23 Bn 7.98 Bn 257.95 Mn -3.26%
5 10x Genomics 8.23 Bn 7.68 Bn 112.50 Mn -4.61%
6 Hinge Health 7.20 Bn 6.81 Bn 183.95 Mn 436.07%
7 MiniMed 6.10 Bn 5.81 Bn 480.00 Mn -969.23%
8 Waystar Holding 4.99 Bn 4.80 Bn 221.99 Mn -52.42%
9 Doximity 4.92 Bn 4.23 Bn 132.93 Mn -34.04%
10 Heartflow 4.30 Bn 3.92 Bn 53.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.61%
Mar 31, 2026 -24.45%
Dec 31, 2025 512.09%
Sep 30, 2025 139.56%
Jun 30, 2025 249.29%
Mar 31, 2025 274.18%
Dec 31, 2024 -142.42%
Sep 30, 2024 143.79%
Jun 30, 2024 142.87%
Mar 31, 2024 46.44%
Dec 31, 2023 185.76%
Sep 30, 2023 12.13%
Jun 30, 2023 75.62%
Mar 31, 2023 28.90%
Dec 31, 2022 -19.25%
Sep 30, 2022 0.66%
Jun 30, 2022 -285.94%
Mar 31, 2022 -13.95%
Dec 31, 2021 85.60%
Sep 30, 2021 17.27%